Katharina Biermann

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.5K citations

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Esophageal Cancer +9

Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial

Esther M. Stoop, Margriet C. de Haan, Thomas R. de Wijkerslooth et al. · The Lancet Oncology · 2011 · 367 citations

Medical Imaging, Cancer Detection, Cancer Screening +11

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Bo Jan Noordman, Manon C.W. Spaander, Roelf Valkema et al. · The Lancet Oncology · 2018 · 320 citations

Residual Disease, Surgical Oncology, Esophageal Cancer +11

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels

Esther Toes‐Zoutendijk, Monique E. van Leerdam, Evelien Dekker et al. · Gastroenterology · 2016 · 216 citations · Full text

First Year, Real-time Monitoring, Oncology +13

Targeted serum miRNA (TSmiR) test for diagnosis and follow‐up of (testicular) germ cell cancer patients: A proof of principle

Ad Gillis, Martin A. Rijlaarsdam, Ronak Eini et al. · Molecular Oncology · 2013 · 157 citations · Full text

Gcc Serum Samples, Pathology, Cancer Biology +16